Virbac, one of the world’s leading companies in animal health, is continuing its expansion in Europe.
In addition to the recent finalization of the creation of its Irish subsidiary, Virbac announces the acquisition of its historical distributor in the Czech Republic and Slovakia, which becomes its 35th subsidiary.
This development strategy strengthens the group’s position in the European market for animal health.
Present in the Czech Republic and Slovakia since 2000 through its historical distributor, Virbac is well aware of these two markets, mainly oriented towards pets and ruminants.
In order to continue the development of its activities in this region and strengthen its presence in Central Europe, Virbac has acquired GS Partners, one of its oldest distributors in this area. This acquisition crowns the excellent work done for years by the teams of Jakub Satrapa, its former owner and future CEO of the Virbac subsidiary.
The new Virbac subsidiary in Ireland and the acquisition of GS Partners in the Czech Republic and Slovakia will allow the group to respond more broadly and quickly to the health needs of animals in these countries. Therefore, this development strategy strengthens Virbac’s position in the European animal health market, where the group continues to grow and expand.
Healthtech & Biotech News – Nice Côte d’Azur France
- Virbac Spain: 40 years of commitment to animal health
- Business Landing Nice Côte d’Azur: Support for business set up in France
- Nice will host Hospital-University Institute dedicated to respiratory health
- Cosmetopôle Provence-Côte d’Azur Meeting: Technology Serving Sustainability
- Virbac acquires its distributor in the Czech Republic and Slovakia to strengthen its presence in Central Europe
- Virbac has created a new subsidiary in Ireland to strengthen its presence in a rapidly growing animal health market
- Bpifrance Provence-Alpes-Côte d’Azur supported 5,426 companies in 2022
- Team Nice Côte d’Azur will participate in the EU Startups Summit 2023
- Microalgae: Inalve is preparing for a new phase of growth towards large-scale and responsible production
- Horus Pharma is continuing its European expansion with the opening of its subsidiary in the Nordic countries.
